This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Rznomics Inc., Dong-A University Research Foundation for Industry-Academy Cooperation, Industry-Academic Cooperation Foundation, Dankook University. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 6 
1 out of 38 
1 out of 65 
Years Active: 2021-2026
Title: Eun Yi Cho: Innovator in Cancer Treatment
Introduction
Eun Yi Cho is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of specialized ribozymes.
Latest Patents
Eun Yi Cho holds a patent for "Cancer-specific trans-splicing ribozymes and use thereof." This invention focuses on a trans-splicing ribozyme that specifically targets cancer tissue while sparing normal tissues. The ribozyme demonstrates high safety and excellent expression efficiency at the post-transcription level, making it a promising tool for cancer treatment.
Career Highlights
Throughout his career, Eun Yi Cho has worked with notable organizations, including Rznomics Inc. and the Dong-a University Research Foundation for Industry-Academy Cooperation. His work has been instrumental in advancing cancer research and therapeutic strategies.
Collaborations
Eun Yi Cho has collaborated with esteemed colleagues such as Seong-Wook Lee and Chang Ho Lee. Their joint efforts have contributed to the development of innovative solutions in the field of cancer treatment.
Conclusion
Eun Yi Cho's work in developing cancer-specific ribozymes showcases his dedication to improving cancer therapies. His innovative approach has the potential to significantly impact the future of cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile